43 JelinekA.HeyderL.DaudeM.PlessnerM.KrippnerS.GrosseR.et al (2018)
Despite the miraculous effect of the drug, its consequences are not fully understood and, therefore, may be dangerous for the unborn child
Not everyone qualifies, and that's intentional - safety comes first
PP, Designing formulation strategies for enhanced stability of therapeutic peptides in aqueous solutions: A review
Haas sit down with peptide expert, keynote speaker, and industry insider Paul Bakhtiar to break down whats really happening behind the scenes in the peptide industry
The MHRA has issued public warnings about the sale of unlicensed peptides and research chemicals marketed for human use, noting that such products may be mislabelled, contaminated, or of unknown potency